Squamous Cell Carcinoma of the Larynx
10 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma of the Larynx
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT04831450) | University of Miami | 2022-07-01 |
| Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03370276) | H. Lee Moffitt Cancer Center and Research Institute | 2017-12-20 |
| Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer (NCT03114462) | M.D. Anderson Cancer Center | 2017-08-09 |
| HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer (NCT02464137) | University of Texas Southwestern Medical Center | 2015-04-27 |
Track Squamous Cell Carcinoma of the Larynx automatically
Every clearance here is in the API, with alerts when new ones post.